查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612589

Biperiden市场：按剂量、按应用 - 全球预测 2025-2030

Biperiden Market by Administration (Injection, Oral), Application (Drug-induced Movement Disorders, Parkinson Disease, Touret Syndrome) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Biperiden市值为3.6427亿美元，预计到2024年将达到3.847亿美元，复合年增长率为5.69%，预计到2030年将达到5.3676亿美元。

Biperiden是一种抗胆碱能药物，主要用于治疗帕金森氏症和相关的运动障碍。Biperiden的市场范围包括其在解决帕金森氏症和其他神经退化性疾病（例如震颤、强直和心搏过缓）的运动症状方面的需求和用途。其最终用途包括医院、诊所和家庭护理机构，在这些场所，老年人特别容易患帕金森氏症，而且这种疾病的发生率正在上升。目前的市场成长受到神经系统疾病发病率增加、意识提高以及更好治疗选择的可用性的影响。然而，也有机会探索药物对次要适应症的功效，特别是在心理健康方面，例如抗精神病药物引起的锥体外系症状的治疗。利用这些机会的建议包括研究和开发改进製剂，使患者更容易获得治疗，例如缓释性释放、提高生物利用度和减少副作用，这包括加强努力。

主要市场统计
基准年[2023] 3.6427 亿美元
预计年份 [2024] 3.847 亿美元
预测年份 [2030] 53676万美元
复合年增长率（%） 5.69%

然而，阻碍市场成长的挑战包括潜在副作用（口干、便秘、视力模糊、混乱）等限制，这可能会妨碍长期使用。来自替代疗法（包括更新、更有效的帕金森氏症疗法）的竞争也构成了威胁。监管障碍以及持续更新安全性和有效性的需要也增加了挑战。这个市场为联合治疗的创新提供了肥沃的土壤，并有可能改善患者的治疗效果。另一个有前景的研究领域是个人化医疗，其使用是根据个人的遗传特征量身定制的，以最大限度地提高疗效并最大限度地减少副作用。Biperiden市场的本质特征是由未满足的临床需求驱动的稳定成长，但受到重大障碍的抑制。与以神经病学为重点的学术机构和生物技术公司的创新和策略联盟对于在动态的製药领域保持竞争力和持续成长至关重要。

市场动态：揭示快速发展的Biperiden市场的关键市场洞察

供需的动态交互作用正在改变比Biperiden市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 扩大比Biperiden在帕金森氏症治疗的全球使用
    • 在治疗药物引起的运动障碍的药物开发中增加Biperiden的使用
  • 市场限制因素
    • 比Biperiden生产认知度低、成本高
  • 市场机会
    • 提高Biperiden登药物适用性的研发进展
    • 製药公司加大对比Biperiden生产的投资
  • 市场问题
    • Biperiden可能对健康的影响

波特的五力：驾驭Biperiden市场的策略工具

波特的五力框架是了解Biperiden市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解Biperiden市场的外部影响

外部宏观环境因素在塑造Biperiden市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解Biperiden市场的竞争格局

Biperiden市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：Biperiden市场供应商的绩效评估

FPNV定位矩阵是评估Biperiden市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製比Biperiden市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，Biperiden市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球Biperiden治疗巴金森氏症的使用量增加
      • 在治疗药物引起的运动障碍的药物开发中增加使用Biperiden
    • 抑制因素
      • 比Biperiden生产认知度低、成本高
    • 机会
      • 持续研发，增强Biperiden药物的适用性
      • 製药公司对比Biperiden生产的新投资
    • 任务
      • 比Biperiden相关的潜在健康影响
  • 市场区隔分析
    • 给药方式：由于易于使用和患者依从性，口服给药越来越受欢迎
    • 用途：Biperiden作为有效抗胆碱能药物在药物引起的运动障碍的推广
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章Biperiden市场：依剂量

  • 介绍
  • 注射
  • 口服

第七章Biperiden市场：依应用

  • 介绍
  • 药物引起的运动障碍
  • 帕金森氏症
  • 妥瑞症

第八章 美洲比Biperiden市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太比哌Biperiden市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲Biperiden市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 默克签署 6.1 亿美元 Biovacs 收购临床前神经退化生物技术公司 Caraway 的协议
    • 艾伯维 (AbbVie) 透过生物技术收购获得帕金森氏症治疗药物
    • Serina 和 AgeX 共同开发进行性帕金森氏症的治疗方法
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AbbVie Inc.
  • ACTYLIS
  • Adooq Bioscience LLC
  • BioCrick BioTech
  • BIoTechne Corporation
  • Clearsynth
  • Enomark
  • MANUS AKTTEVA BIOPHARMA LLP
  • Merck KGaA
  • NIKSAN PHARMACEUTICAL
  • Rafa Laboratories Ltd.
  • SAKHIYA PHARMA CHEM
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Shreeji Pharma International
  • Simson Pharma
  • Synnat Pharma
Product Code: MRR-351BAD503D4E

The Biperiden Market was valued at USD 364.27 million in 2023, expected to reach USD 384.70 million in 2024, and is projected to grow at a CAGR of 5.69%, to USD 536.76 million by 2030.

Biperiden is an anticholinergic drug primarily used to treat Parkinson's disease and related movement disorders. The market scope for Biperiden encompasses its necessity and application in addressing the motor symptoms of Parkinson's and other neurodegenerative conditions, including tremors, rigidity, and bradykinesia. Its end-use spans hospitals, clinics, and home care settings, particularly given the rising geriatric population vulnerable to Parkinson's. Current market growth is influenced by increasing incidences of neurological disorders, greater awareness, and the availability of better treatment options. However, opportunities also lie in exploring the drug's efficacy for secondary indications, especially within mental health, such as managing extrapyramidal symptoms induced by antipsychotics. A recommendation to capitalize on these opportunities includes intensifying R&D efforts to improve Biperiden formulations that offer extended release, enhance bioavailability, and lower side-effect profiles, thus making the treatment more patient-friendly.

KEY MARKET STATISTICS
Base Year [2023] USD 364.27 million
Estimated Year [2024] USD 384.70 million
Forecast Year [2030] USD 536.76 million
CAGR (%) 5.69%

Yet, challenging the market growth are limitations such as potential adverse effects (dry mouth, constipation, blurred vision, confusion), which may deter long-term use. Competition from alternative therapies, including newer, more effective Parkinson's drugs, also poses a threat. Regulatory hurdles and the necessity for continuous updates on safety and efficacy add to the challenges. Nonetheless, the market offers fertile ground for innovation in the form of combination therapies that may enhance patient outcomes. Another promising research area lies in personalized medicine, tailoring Biperiden use to individual genetic profiles to maximize efficacy and minimize side effects. The nature of the Biperiden market is one characterized by steady growth, driven by unmet clinical needs but tempered by significant barriers. Innovation and strategic collaborations with academic institutions and biotech firms focused on neurology will be essential to maintain competitiveness and to sustain growth in the dynamic pharmaceutical landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biperiden Market

The Biperiden Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use of biperiden to treat parkinson's disease globally
    • Rising usage of biperiden in drug developement of drug-induced movement disorders
  • Market Restraints
    • Limited awareness and high cost of biperiden manufacturing
  • Market Opportunities
    • Ongoing research and development to enhance the applicability of biperiden-based drugs
    • Emerging investments by pharmaceutical companies in biperiden production
  • Market Challenges
    • Potential health affects associated with biperiden

Porter's Five Forces: A Strategic Tool for Navigating the Biperiden Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biperiden Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biperiden Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biperiden Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biperiden Market

A detailed market share analysis in the Biperiden Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biperiden Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biperiden Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biperiden Market

A strategic analysis of the Biperiden Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biperiden Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., ACTYLIS, Adooq Bioscience LLC, BioCrick BioTech, Biotechne Corporation, Clearsynth, Enomark, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN PHARMACEUTICAL, Rafa Laboratories Ltd., SAKHIYA PHARMA CHEM, Salvavidas Pharmaceutical Pvt. Ltd., Shreeji Pharma International, Simson Pharma, and Synnat Pharma.

Market Segmentation & Coverage

This research report categorizes the Biperiden Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Administration, market is studied across Injection and Oral.
  • Based on Application, market is studied across Drug-induced Movement Disorders, Parkinson Disease, and Touret Syndrome.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of biperiden to treat parkinson's disease globally
      • 5.1.1.2. Rising usage of biperiden in drug developement of drug-induced movement disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and high cost of biperiden manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to enhance the applicability of biperiden-based drugs
      • 5.1.3.2. Emerging investments by pharmaceutical companies in biperiden production
    • 5.1.4. Challenges
      • 5.1.4.1. Potential health affects associated with biperiden
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance
    • 5.2.2. Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biperiden Market, by Administration

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Oral

7. Biperiden Market, by Application

  • 7.1. Introduction
  • 7.2. Drug-induced Movement Disorders
  • 7.3. Parkinson Disease
  • 7.4. Touret Syndrome

8. Americas Biperiden Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biperiden Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biperiden Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Merck Seals USD 610 Million Biobucks Deal to Acquire Preclinical Neurodegenerative Biotech Caraway
    • 11.3.2. AbbVie Acquires Parkinson's Drug in Latest Biotech Buyout
    • 11.3.3. Serina-AgeX Merger to Develop Treatment for Advanced Parkinson's
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. ACTYLIS
  • 4. Adooq Bioscience LLC
  • 5. BioCrick BioTech
  • 6. Biotechne Corporation
  • 7. Clearsynth
  • 8. Enomark
  • 9. MANUS AKTTEVA BIOPHARMA LLP
  • 10. Merck KGaA
  • 11. NIKSAN PHARMACEUTICAL
  • 12. Rafa Laboratories Ltd.
  • 13. SAKHIYA PHARMA CHEM
  • 14. Salvavidas Pharmaceutical Pvt. Ltd.
  • 15. Shreeji Pharma International
  • 16. Simson Pharma
  • 17. Synnat Pharma

LIST OF FIGURES

  • FIGURE 1. BIPERIDEN MARKET RESEARCH PROCESS
  • FIGURE 2. BIPERIDEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIPERIDEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIPERIDEN MARKET DYNAMICS
  • TABLE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023